242 related articles for article (PubMed ID: 23832079)
21. Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type.
Cadena SM; Tomkinson KN; Monnell TE; Spaits MS; Kumar R; Underwood KW; Pearsall RS; Lachey JL
J Appl Physiol (1985); 2010 Sep; 109(3):635-42. PubMed ID: 20466801
[TBL] [Abstract][Full Text] [Related]
22. Sarcopenia: a histological and immunohistochemical study on age-related muscle impairment.
Tarantino U; Scimeca M; Piccirilli E; Tancredi V; Baldi J; Gasbarra E; Bonanno E
Aging Clin Exp Res; 2015 Oct; 27 Suppl 1():S51-60. PubMed ID: 26197719
[TBL] [Abstract][Full Text] [Related]
23. Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells.
Bowser M; Herberg S; Arounleut P; Shi X; Fulzele S; Hill WD; Isales CM; Hamrick MW
Exp Gerontol; 2013 Feb; 48(2):290-7. PubMed ID: 23178301
[TBL] [Abstract][Full Text] [Related]
24. Administration of a mutated myostatin propeptide to neonatal mice significantly enhances skeletal muscle growth.
Li Z; Zhao B; Kim YS; Hu CY; Yang J
Mol Reprod Dev; 2010 Jan; 77(1):76-82. PubMed ID: 19743472
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin-Deficient Diabetic Mice.
Bunn RC; Adatorwovor R; Smith RR; Ray PD; Fields SE; Keeble AR; Fry CS; Uppuganti S; Nyman JS; Fowlkes JL; Kalaitzoglou E
JBMR Plus; 2023 Nov; 7(11):e10833. PubMed ID: 38025035
[TBL] [Abstract][Full Text] [Related]
26. A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.
Boido M; Butenko O; Filippo C; Schellino R; Vrijbloed JW; Fariello RG; Vercelli A
PLoS One; 2020; 15(3):e0228653. PubMed ID: 32160187
[TBL] [Abstract][Full Text] [Related]
27. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading.
Spatz JM; Ellman R; Cloutier AM; Louis L; van Vliet M; Suva LJ; Dwyer D; Stolina M; Ke HZ; Bouxsein ML
J Bone Miner Res; 2013 Apr; 28(4):865-74. PubMed ID: 23109229
[TBL] [Abstract][Full Text] [Related]
28. Muscle-specific transgenic expression of porcine myostatin propeptide enhances muscle growth in mice.
Wang K; Li Z; Li Y; Zeng J; He C; Yang J; Liu D; Wu Z
Transgenic Res; 2013 Oct; 22(5):1011-9. PubMed ID: 23543410
[TBL] [Abstract][Full Text] [Related]
29. Combinatorial Inhibition of Myostatin and Activin A Improves Femoral Bone Properties in the G610C Mouse Model of Osteogenesis Imperfecta.
Omosule CL; Joseph D; Weiler B; Gremminger VL; Silvey S; Jeong Y; Rafique A; Krueger P; Kleiner S; Phillips CL
J Bone Miner Res; 2022 May; 37(5):938-953. PubMed ID: 35195284
[TBL] [Abstract][Full Text] [Related]
30. Prolonged absence of myostatin reduces sarcopenia.
Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
[TBL] [Abstract][Full Text] [Related]
31. The effect of high-fat diet on the morphological properties of the forelimb musculature in hypertrophic myostatin null mice.
Elashry MI; Eldaey A; Glenske K; Matsakas A; Wenisch S; Arnhold S; Patel K
J Anat; 2019 Oct; 235(4):825-835. PubMed ID: 31198988
[TBL] [Abstract][Full Text] [Related]
32. Grip force, EDL contractile properties, and voluntary wheel running after postdevelopmental myostatin depletion in mice.
Personius KE; Jayaram A; Krull D; Brown R; Xu T; Han B; Burgess K; Storey C; Shah B; Tawil R; Welle S
J Appl Physiol (1985); 2010 Sep; 109(3):886-94. PubMed ID: 20595537
[TBL] [Abstract][Full Text] [Related]
33. Co-Administration of Myostatin-Targeting siRNA and ActRIIB-Fc Fusion Protein Increases Masseter Muscle Mass and Fiber Size.
Bayarsaikhan O; Kawai N; Mori H; Kinouchi N; Nikawa T; Tanaka E
J Nutr Sci Vitaminol (Tokyo); 2017; 63(4):244-248. PubMed ID: 28978871
[TBL] [Abstract][Full Text] [Related]
34. Osteoprotegerin is an effective countermeasure for spaceflight-induced bone loss in mice.
Lloyd SA; Morony SE; Ferguson VL; Simske SJ; Stodieck LS; Warmington KS; Livingston EW; Lacey DL; Kostenuik PJ; Bateman TA
Bone; 2015 Dec; 81():562-572. PubMed ID: 26318907
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD).
Harish P; Malerba A; Lu-Nguyen N; Forrest L; Cappellari O; Roth F; Trollet C; Popplewell L; Dickson G
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1016-1026. PubMed ID: 31066242
[TBL] [Abstract][Full Text] [Related]
36. Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
Zhang Y; Wang L; Song Y; Zhao X; Wong MS; Zhang W
Osteoporos Int; 2016 Mar; 27(3):1083-1092. PubMed ID: 26439241
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.
Whittemore LA; Song K; Li X; Aghajanian J; Davies M; Girgenrath S; Hill JJ; Jalenak M; Kelley P; Knight A; Maylor R; O'Hara D; Pearson A; Quazi A; Ryerson S; Tan XY; Tomkinson KN; Veldman GM; Widom A; Wright JF; Wudyka S; Zhao L; Wolfman NM
Biochem Biophys Res Commun; 2003 Jan; 300(4):965-71. PubMed ID: 12559968
[TBL] [Abstract][Full Text] [Related]
38. Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfecta.
Oestreich AK; Kamp WM; McCray MG; Carleton SM; Karasseva N; Lenz KL; Jeong Y; Daghlas SA; Yao X; Wang Y; Pfeiffer FM; Ellersieck MR; Schulz LC; Phillips CL
Proc Natl Acad Sci U S A; 2016 Nov; 113(47):13522-13527. PubMed ID: 27821779
[TBL] [Abstract][Full Text] [Related]
39. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
Yao W; Dai W; Jiang L; Lay EY; Zhong Z; Ritchie RO; Li X; Ke H; Lane NE
Osteoporos Int; 2016 Jan; 27(1):283-294. PubMed ID: 26384674
[TBL] [Abstract][Full Text] [Related]
40. Functional improvement of dystrophic muscle by myostatin blockade.
Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
